89Zr-bevacizumab PET Imaging in Patients With Renal Cell Carcinoma Treated With Everolimus; a Pilot Study
Phase of Trial: Phase IV
Latest Information Update: 29 Sep 2015
At a glance
- Drugs Everolimus (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 27 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Nov 2014 Planned End Date changed from 1 Dec 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 18 Nov 2014 Planned primary completion date changed from 1 Oct 2014 to 1 Feb 2015, according to ClinicalTrials.gov.